Circulating levels of copeptin, a novel biomarker, in lower respiratory tract infections

Abstract

Copeptin levels are increased with increasing severity of LRTI namely in patients with CAP and unfavourable outcome. Copeptin levels, as a novel biomarker, might be a useful tool in the risk stratification of patients with LRTI.